XOMA Corporation (XOMA) was a big mover last session, as the company saw its shares jump a little over 22% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend of the company, as the stock is now up over 35.8% in the past one-month time frame.
In the last 30 days, the company has seen 3 negative revisions, while the Zacks Consensus Estimate, currently at a loss, widened in the same period, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
XOMA currently has a Zacks Rank #4 (Sell) while its Earnings ESP is negative.
Some better-ranked biotechnology stocks include Heska Corporation (HSKA), Actelion Ltd. (ALIOF) and AMAG Pharmaceuticals, Inc. (AMAG). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
XOMA CORP (XOMA): Free Stock Analysis Report
HESKA CORP (HSKA): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
AMAG PHARMACEUTICALS INC (AMAG): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies